Botulinum Toxin-A for Hidradenitis Suppurativa
Megadott ok: Study never officially began (or enrolled)
A legfontosabb adatok
- Hol
- Guilford (Egyesült Államok)A helyszín megnézése
- Fázis
- 4. fázis
Helyszínek itt: Egyesült Államok
- Yale Medicine Multispecialty ClinicGuilford, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- Yale University
- Azonosító
- NCT06237465
- A regiszteradat frissítve
- 2025. december 16.
- Eredeti leírás
The purpose of this research study is to determine if the medication Botulinum Toxin-A (BTX-A) is effective in treating hidradenitis suppurativa (HS)A teljes eredeti leírásKevesebb
The purpose of this research study is to determine if the medication Botulinum Toxin-A (BTX-A) is effective in treating hidradenitis suppurativa (HS)
Bevonási feltételek: Subjects with active axillary hidradenitis suppurativa of the same severity bilaterally. regimen; For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation; Agreement to forego other treatments for hidradenitis for the duration of the study.
Kizáró feltételek: Current use of antibiotics, hormonal therapies, steroids, and/or biologics; Treatment with another investigational drug or other intervention within three months; Presence of cardiac pacemaker; Known neuromuscular disorder; Febrile illness within one month; Pregnancy or lactation; Known hyperhidrosis; Patients without active axillary hidradenitis suppurativa.